US FDA pushes decision on Moderna's RSV vaccine to end of this month
STORY CONTINUES BELOW THESE SALTWIRE VIDEOS (Reuters) - The U.S. Food and Drug Administration has pushed back its decision on Moderna's respiratory syncytial virus (RSV) vaccine by more than two weeks to the end of this month due to some " …